Thank you for visiting us
Moletest Limited has created a medical device that runs on ios devices designed for use by Medical Professionals. It is called, nomela®.

It assesses risk of malignancy for a pigmented skin lesion (mole) to reduce unneeded referrals safely.

Why you need
Nearly 97% of skin lesion referrals are unnecessary.

This is caused by over-dependence on subjective examination and answers to clinical questions.
Moletest's nomela® has been developed to help medical professionals assess skin lesions more effectively and so avoid unneeded referrals.
To provide GPs with a simple risk assessment tool to screen out non-malignant lesions efficiently and reliably.

To provide effective referral information to enable comparative analysis and appropriate treatment.
What is
Our Objectives
HOME
PRODUCT
CONTACT
Home
Product
Contact Us
Made with HTML Egg on a Mac
© Moletest Limited
?